Coya Therapeutics
COYA
54 hedge funds and large institutions have $45.5M invested in Coya Therapeutics in 2026 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 7 closing their positions.
42% more capital invested
Capital invested by funds: $32M → $45.5M (+$13.4M)
1.42% less ownership
Funds ownership: 34.56% → 33.15% (-1.4%)
4% less funds holding
Funds holding: 56 → 54 (-2)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$412K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$371K |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
+$305K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$278K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
+$143K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.59M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$1.16M |
| 3 |
6CM
683 Capital Management
New York
|
-$276K |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$148K |
| 5 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
-$142K |
COYA Hedge Fund Activity: Q2 2026 in Review
54 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q2 2026, worth a combined $45.5M — up 42% from $32M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of COYA and 5 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 14 added.
The largest buyer was Renaissance Technologies, adding an estimated $412K. The largest seller was AIGH Capital Management, cutting an estimated $1.59M.
- 54 institutional investors held Coya Therapeutics (COYA) as of Q2 2026, down from 56 in Q1 2026.
- Funds reported $45.5M of Coya Therapeutics stock for Q2 2026, up 42% quarter-over-quarter.
- 5 funds opened new Coya Therapeutics positions in Q2 2026 and 7 closed out, a net change of -2 holders.
- The largest Coya Therapeutics buyer in Q2 2026 was Renaissance Technologies, an estimated $412K added.
- The largest Coya Therapeutics seller in Q2 2026 was AIGH Capital Management, an estimated $1.59M sold.
Based on aggregated 13F filings for Q2 2026.